» Articles » PMID: 15580208

Clinical and Behavioral Features of Patients with Borjeson-Forssman-Lehmann Syndrome with Mutations in PHF6

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2004 Dec 8
PMID 15580208
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe clinical and behavioral features of 10 men from 2 families with Borjeson-Forssman-Lehmann syndrome (BFLS) and missense mutations in the PHF6 zinc-finger transcription factor gene.

Study Design: BFLS behavioral features were compared with other age-matched men with other syndromes and similar intellectual functioning through the use of standardized questionnaires: the Child Behavior Checklist, the Vineland Adaptive Behavior Scales, and the Reiss Personality Profile. Participants included 10 with BFLS, 10 with Prader-Willi syndrome, and 23 with Klinefelter syndrome variants (13 with 48,XXYY, 4 with 48,XXXY, and 6 with 49,XXXXY).

Results: Contrary to initial reports, our men with BFLS had no microcephaly, seizures, or short stature. They manifested deep-set eyes with large ears, coarse facial features, small external genitalia, gynecomastia, and obesity. Family A had mild to moderate mental retardation, whereas family B was more severely affected. On Vineland Adaptive Behavior Scales, men with BFLS had higher daily living and social skills than communicative skills. Men with BFLS also had lower internalizing and externalizing symptoms and appeared more social and helpful than men with Prader-Willi syndrome or Klinefelter syndrome variant.

Conclusions: Men with BFLS from 2 families with mutations in the PHF6 gene manifested distinctive clinical features and a low risk for maladaptive behaviors.

Citing Articles

Leukemia-mutated proteins PHF6 and PHIP form a chromatin complex that represses acute myeloid leukemia stemness.

Pawar A, Somers P, Alex A, George S, Antony C, Verner R bioRxiv. 2024; .

PMID: 39677666 PMC: 11642813. DOI: 10.1101/2024.11.29.625909.


Borjeson-Forssman-Lehmann Syndrome: Clinical Features and Diagnostic Challenges.

Hameed M, Siddiqui F, Sheikh F, Khan M, Admani B, Gangishetti P Brain Neurorehabil. 2023; 16(3):e32.

PMID: 38047102 PMC: 10689860. DOI: 10.12786/bn.2023.16.e32.


Ribosome biogenesis and function in development and disease.

Ni C, Buszczak M Development. 2023; 150(5).

PMID: 36897354 PMC: 10108708. DOI: 10.1242/dev.201187.


Transgenic mice with an R342X mutation in Phf6 display clinical features of Börjeson-Forssman-Lehmann Syndrome.

Ahmed R, Sarwar S, Hu J, Cardin V, Qiu L, Zapata G Hum Mol Genet. 2021; 30(7):575-594.

PMID: 33772537 PMC: 8120135. DOI: 10.1093/hmg/ddab081.


Chromatin regulators and their impact on DNA repair and G2 checkpoint recovery.

Smits V, Vega I, Warmerdam D Cell Cycle. 2020; 19(17):2083-2093.

PMID: 32730133 PMC: 7513856. DOI: 10.1080/15384101.2020.1796037.